Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-06 12:40 pm Purchase | 2024-03-04 | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Frazier Life Sciences VIII, L.P. | 8,862,478 7.800% | 21,052![]() (+0.24%) | Filing History |
| 2024-03-06 10:31 am Purchase | 2024-03-06 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Jennison Associates LLC | 12,128,533 10.800% | 3,062,451![]() (+33.78%) | Filing History |
| 2024-02-14 3:58 pm Purchase | 2024-02-14 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 9,884,137 10.470% | 233,326![]() (+2.42%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | VANGUARD GROUP INC | 4,896,513 5.190% | 4,896,513![]() (New Position) | Filing History |
| 2024-02-13 12:29 pm Sale | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Montanova Capital, LLC | 9,534,837 9.990% | -57,375![]() (-0.60%) | Filing History |
| 2024-02-13 09:26 am Sale | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Polar Capital Holdings Plc | 6,297,688 6.670% | -820,256![]() (-11.52%) | Filing History |
| 2024-02-12 09:52 am Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Morgan Stanley MS | 6,093,497 6.500% | 6,093,497![]() (New Position) | Filing History |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Rubric Capital Management LP | 6,644,530 7.040% | 6,644,530![]() (New Position) | Filing History |
| 2024-02-08 12:52 pm Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Jennison Associates LLC | 9,066,082 9.600% | 9,066,082![]() (New Position) | Filing History |
| 2024-01-31 4:54 pm Purchase | 2024-01-30 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management, L.P. | 4,867,706 5.200% | 3,680,108![]() (+309.88%) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | BlackRock Inc. BLK | 5,916,546 6.300% | 2,036,144![]() (+52.47%) | Filing History |
| 2024-01-23 10:26 am Sale | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | STATE STREET CORP STT | 1,525,045 1.620% | -2,154,340![]() (-58.55%) | Filing History |
| 2023-11-16 1:13 pm Purchase | 2023-10-20 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Polar Capital Holdings Plc | 7,117,944 7.560% | 7,117,944![]() (New Position) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | FMR LLC | 3,551,261 3.771% | -5,587,912![]() (-61.14%) | Filing History |
| 2023-11-09 2:54 pm Purchase | 2023-11-09 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | PRUDENTIAL FINANCIAL INC PRU | 9,650,811 10.250% | 9,650,811![]() (New Position) | Filing History |
| 2023-11-07 3:33 pm Sale | 2023-10-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | BlackRock Inc. BLK | 3,880,402 4.100% | -1,333,856![]() (-25.58%) | Filing History |
| 2023-10-30 5:03 pm Purchase | 2023-10-20 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Montanova Capital, LLC | 9,592,212 9.990% | 9,592,212![]() (New Position) | Filing History |
| 2023-10-26 4:11 pm Purchase | 2023-10-24 | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Frazier Life Sciences VIII, L.P. | 8,841,426 9.400% | 96,108![]() (+1.10%) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management, L.P. | 1,187,598 1.900% | -1,470,364![]() (-55.32%) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | FMR LLC | 9,139,173 14.999% | 1,594,961![]() (+21.14%) | Filing History |

